DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,323,705 | +16.4% | 9,366 | +12.6% | 0.30% | +9.4% |
| Q2 2023 | $1,996,320 | -4.9% | 8,318 | -0.2% | 0.28% | -11.5% |
| Q1 2023 | $2,100,249 | -12.7% | 8,333 | -8.1% | 0.31% | -16.5% |
| Q4 2022 | $2,405,501 | -0.0% | 9,063 | -2.7% | 0.38% | -5.1% |
| Q3 2022 | $2,406,000 | +4.8% | 9,314 | +2.9% | 0.40% | +7.6% |
| Q2 2022 | $2,295,000 | -19.6% | 9,051 | -7.0% | 0.37% | -2.6% |
| Q1 2022 | $2,855,000 | -0.6% | 9,732 | +11.4% | 0.38% | +3.8% |
| Q4 2021 | $2,873,000 | +9.1% | 8,733 | +0.9% | 0.36% | +2.0% |
| Q3 2021 | $2,634,000 | +13.5% | 8,653 | +0.1% | 0.36% | +13.7% |
| Q2 2021 | $2,321,000 | +64.1% | 8,648 | +37.6% | 0.31% | +47.4% |
| Q1 2021 | $1,414,000 | +26.0% | 6,283 | +24.3% | 0.21% | +18.3% |
| Q4 2020 | $1,122,000 | +8.6% | 5,053 | +5.3% | 0.18% | -9.1% |
| Q3 2020 | $1,033,000 | +36.1% | 4,798 | +11.8% | 0.20% | +23.0% |
| Q2 2020 | $759,000 | +43.2% | 4,293 | +12.2% | 0.16% | +12.6% |
| Q1 2020 | $530,000 | -4.2% | 3,827 | +6.2% | 0.14% | +12.6% |
| Q4 2019 | $553,000 | – | 3,602 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |